FDA Requests Public Comments on Direct-to-Consumer Prescription Drug Advertising Survey

Summary

The Food and Drug Administration (FDA) has submitted a proposed survey to the Office of Management and Budget (OMB) for review under the Paperwork Reduction Act of 1995, seeking public input on the effects of direct-to-consumer advertising of prescription drugs.